Orthofix Medical (OFIX) Receivables (2010 - 2026)

Orthofix Medical (OFIX) has 17 years of Receivables data on file, last reported at $137.8 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables rose 4.48% year-over-year to $137.8 million; the trailing twelve-month figure through Mar 2026 stood at $137.8 million (up 4.48% YoY), and the FY2025 full-year result was $135.7 million, up 0.77% from the prior year.
• Receivables for Q1 2026 stood at $137.8 million, up from $135.7 million in the prior quarter.
• Across five years, Receivables topped out at $137.8 million in Q1 2026 and bottomed at $72.5 million in Q1 2022.
• A 5-year average of $114.8 million and a median of $125.4 million in 2024 frame the typical range for Receivables.
• Across the five-year window, Receivables surged 56.37% in 2023 and gained 0.77% in 2025, its largest moves.
• Tracing OFIX's Receivables over 5 years: stood at $82.9 million in 2022, then soared by 54.6% to $128.1 million in 2023, then advanced by 5.16% to $134.7 million in 2024, then increased by 0.77% to $135.7 million in 2025, then rose by 1.49% to $137.8 million in 2026.
• According to Business Quant data, Receivables over the past three periods registered $137.8 million, $135.7 million, and $130.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison